VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Fleisher Discusses Monitoring Patients With ONJ

Kenneth E. Fleisher, DDS
Published: Monday, Nov 21, 2011

Kenneth E. Fleisher, DDS, Assistant Professor, Oral and Maxillofacial Surgery, New York University, College of Dentistry, explains the steps that oncology nurses can take to monitor patients with osteonecrosis of the jaw (ONJ).

During the clinical exam nurses should ask patients who their dentist is, what treatment or management they have received, and if they saw or were evaluated by a surgeon. Once these initial items are established the nurse should inquire into the treatment that is being given, whether it is antibiotics or a rinse, and if the patient's condition is improving.

If nurses detect a patient who's condition is worsening they should establish if the symptoms are progressive, getting worse, the amount of exposed bone, a worsening clinical exam, or degraded neurological symptoms. If the patient’s condition is worsening a new or alternative treatment should be considered.

Kenneth E. Fleisher, DDS, Assistant Professor, Oral and Maxillofacial Surgery, New York University, College of Dentistry, explains the steps that oncology nurses can take to monitor patients with osteonecrosis of the jaw (ONJ).

During the clinical exam nurses should ask patients who their dentist is, what treatment or management they have received, and if they saw or were evaluated by a surgeon. Once these initial items are established the nurse should inquire into the treatment that is being given, whether it is antibiotics or a rinse, and if the patient's condition is improving.

If nurses detect a patient who's condition is worsening they should establish if the symptoms are progressive, getting worse, the amount of exposed bone, a worsening clinical exam, or degraded neurological symptoms. If the patient’s condition is worsening a new or alternative treatment should be considered.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x